Kit ELISA sandwich DMP1 (human): quantitative determination of Hu DMP1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu DMP1.
Accession number
Q13316
Dose range
163.8-40.000 pg/ml
Sensitivity of the dosage
80 pg/ml
Calibration range
80 pg/ml to 40000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA sandwich DMP1 (human): quantitative determination of Hu DMP1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu DMP1.
Kit ELISA sandwich DMP1 (human): quantitative determination of Hu DMP1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu DMP1.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
DMP-1 (protein 1 of the dentine matrix), also known as the acid phosphoprotein 1 of the dentine matrix, is part of the small family of glycoproteins bound to d-integrin ligand. It is important for mineralization of bones and dentine. DMP-1 is expressed in bone, dental and hypertrophic cartilage. It is synthesized by preosteoblasts and contains a large number of acidic domains. DMP-1 is located at the non-differentiated d-osteoblast nucleus where it functions as a transcriptional regulator for l-osteoblast-specific genetic activation and induces osteoblast differentiation. During the maturation of l-osteoblast, DMP-1 undergoes a conformational change and becomes phosphorylated by casein kinase II in response to an influx of calcium ions to the nucleus. DMP-1 is then exported to the extracellular matrix (ECM) where it regulates the nucleation of l-hydroxyapatite and the formation of calcified tissue. DMP-1 is proteolytically treated with N-terminal and C-terminal fragments in the MEC of ls and dentin. The protein was also identified in ls as a high molecular weight proteoglycan consisting of N-terminal end DMP-1 fragment and chondroitin sulphate. Loss of DMP-1 may result in hypomineralized bone.